EP Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,082
Closed -$703K 445
2019
Q3
$703K Buy
7,082
+12
+0.2% +$1.14K 0.03% 198
2019
Q2
$654K Sell
7,070
-2,708
-28% -$257K 0.04% 172
2019
Q1
$922K Sell
9,778
-7,151
-42% -$625K 0.09% 117
2018
Q4
$1.08M Sell
16,929
-9,925
-37% -$733K 0.08% 120
2018
Q3
$2.4M Buy
26,854
+1,036
+4% +$91.6K 0.19% 66
2018
Q2
$2.05M Buy
+25,818
New +$2.14M 0.19% 63
2016
Q4
Sell
-2,631
Closed -$275K 159
2016
Q3
$275K Buy
+2,631
New +$285K 0.04% 114

Other funds holding CELG

EP Wealth Advisors's CELG Position: Q4 2019 in Review

EP Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,082 shares — an estimated $703K sold.

EP Wealth Advisors first reported a position in CELG in Q3 2016 and held it in 7 quarters. The position peaked at $2.4M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • EP Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • EP Wealth Advisors sold 7,082 Celgene Corp shares in Q4 2019, an estimated $703K.
  • EP Wealth Advisors first reported a position in Celgene Corp in Q3 2016 and held it in 7 quarters.
  • EP Wealth Advisors's Celgene Corp position peaked at $2.4M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on EP Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.